How shingles vaccines may reduce dementia risk

Introduction to shingles and dementia

Shingles, a reactivation of the varicella-zoster virus that causes chickenpox, can lead to severe health issues, especially in older adults. Recently, studies have suggested that vaccines against shingles could also play a role in reducing the risk of dementia. This connection has been observed with the introduction of newer vaccines that offer more effective protection against the virus.

Comparing old and new shingles vaccines

The older shingles vaccine, Zostavax, used a live virus and was commonly administered until it was phased out in favor of Shingrix, a recombinant vaccine introduced in 2017. Research indicates that Shingrix not only offers better protection against shingles but also reduces the risk of developing dementia by an additional 17% compared to Zostavax.

Study findings on dementia prevention

A recent study led by researchers at the University of Oxford analyzed medical records from over 200,000 individuals who received either the old or new vaccine. Those vaccinated with Shingrix after its launch showed a significantly lower incidence of dementia over the following six years. This suggests that the improved immune response generated by the recombinant vaccine might be more effective at protecting brain health.

Broader implications for healthspan and lifespan

The potential for vaccines to reduce dementia risk extends beyond just shingles vaccines. Other types, like the BCG vaccine used against tuberculosis, have also been associated with a reduced risk of dementia. These findings highlight the importance of vaccinations in potentially extending healthspan and improving long-term health outcomes.

Conclusion

While more research is needed to fully understand the mechanisms behind vaccines' protective effects against dementia, current evidence supports the broader use of newer, more effective vaccines like Shingrix. As the population ages, such preventive measures could be crucial in managing healthspan and lifespan, ultimately reducing the burden of age-related diseases such as dementia.

Source